A Diagnostic Approach for Cerebral Palsy in the Genomic Era

Ryan W. Lee, Andrea Poretti, Julie S. Cohen, Eric Levey, Hilary Gwynn, Michael V. Johnston, Alexander H. Hoon, Ali Fatemi

Research output: Contribution to journalArticle

Abstract

An ongoing challenge in children presenting with motor delay/impairment early in life is to identify neurogenetic disorders with a clinical phenotype, which can be misdiagnosed as cerebral palsy (CP). To help distinguish patients in these two groups, conventional magnetic resonance imaging of the brain has been of great benefit in “unmasking” many of these genetic etiologies and has provided important clues to differential diagnosis in others. Recent advances in molecular genetics such as chromosomal microarray and next-generation sequencing have further revolutionized the understanding of etiology by more precisely classifying these disorders with a molecular cause. In this paper, we present a review of neurogenetic disorders masquerading as cerebral palsy evaluated at one institution. We have included representative case examples children presenting with dyskinetic, spastic, and ataxic phenotypes, with the intent to highlight the time-honored approach of using clinical tools of history and examination to focus the subsequent etiologic search with advanced neuroimaging modalities and molecular genetic tools. A precise diagnosis of these masqueraders and their differentiation from CP is important in terms of therapy, prognosis, and family counseling. In summary, this review serves as a continued call to remain vigilant for current and other to-be-discovered neurogenetic masqueraders of cerebral palsy, thereby optimizing care for patients and their families.

Original languageEnglish (US)
Pages (from-to)821-844
Number of pages24
JournalNeuroMolecular Medicine
Volume16
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Cerebral Palsy
Molecular Biology
Phenotype
Family Therapy
Muscle Spasticity
Diagnostic Errors
Neuroimaging
Counseling
Differential Diagnoses
History
Magnetic Resonance Imaging
Brain

Keywords

  • Cerebral palsy
  • Masqueraders
  • Neurogenetic
  • Spastic, dyskinetic, and ataxic phenotypes

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Molecular Medicine
  • Neurology
  • Medicine(all)

Cite this

A Diagnostic Approach for Cerebral Palsy in the Genomic Era. / Lee, Ryan W.; Poretti, Andrea; Cohen, Julie S.; Levey, Eric; Gwynn, Hilary; Johnston, Michael V.; Hoon, Alexander H.; Fatemi, Ali.

In: NeuroMolecular Medicine, Vol. 16, No. 4, 2014, p. 821-844.

Research output: Contribution to journalArticle

Lee, Ryan W.; Poretti, Andrea; Cohen, Julie S.; Levey, Eric; Gwynn, Hilary; Johnston, Michael V.; Hoon, Alexander H.; Fatemi, Ali / A Diagnostic Approach for Cerebral Palsy in the Genomic Era.

In: NeuroMolecular Medicine, Vol. 16, No. 4, 2014, p. 821-844.

Research output: Contribution to journalArticle

@article{8718ee5ec6fd446bb25425e1832ceff5,
title = "A Diagnostic Approach for Cerebral Palsy in the Genomic Era",
abstract = "An ongoing challenge in children presenting with motor delay/impairment early in life is to identify neurogenetic disorders with a clinical phenotype, which can be misdiagnosed as cerebral palsy (CP). To help distinguish patients in these two groups, conventional magnetic resonance imaging of the brain has been of great benefit in “unmasking” many of these genetic etiologies and has provided important clues to differential diagnosis in others. Recent advances in molecular genetics such as chromosomal microarray and next-generation sequencing have further revolutionized the understanding of etiology by more precisely classifying these disorders with a molecular cause. In this paper, we present a review of neurogenetic disorders masquerading as cerebral palsy evaluated at one institution. We have included representative case examples children presenting with dyskinetic, spastic, and ataxic phenotypes, with the intent to highlight the time-honored approach of using clinical tools of history and examination to focus the subsequent etiologic search with advanced neuroimaging modalities and molecular genetic tools. A precise diagnosis of these masqueraders and their differentiation from CP is important in terms of therapy, prognosis, and family counseling. In summary, this review serves as a continued call to remain vigilant for current and other to-be-discovered neurogenetic masqueraders of cerebral palsy, thereby optimizing care for patients and their families.",
keywords = "Cerebral palsy, Masqueraders, Neurogenetic, Spastic, dyskinetic, and ataxic phenotypes",
author = "Lee, {Ryan W.} and Andrea Poretti and Cohen, {Julie S.} and Eric Levey and Hilary Gwynn and Johnston, {Michael V.} and Hoon, {Alexander H.} and Ali Fatemi",
year = "2014",
doi = "10.1007/s12017-014-8331-9",
volume = "16",
pages = "821--844",
journal = "NeuroMolecular Medicine",
issn = "1535-1084",
publisher = "Humana Press",
number = "4",

}

TY - JOUR

T1 - A Diagnostic Approach for Cerebral Palsy in the Genomic Era

AU - Lee,Ryan W.

AU - Poretti,Andrea

AU - Cohen,Julie S.

AU - Levey,Eric

AU - Gwynn,Hilary

AU - Johnston,Michael V.

AU - Hoon,Alexander H.

AU - Fatemi,Ali

PY - 2014

Y1 - 2014

N2 - An ongoing challenge in children presenting with motor delay/impairment early in life is to identify neurogenetic disorders with a clinical phenotype, which can be misdiagnosed as cerebral palsy (CP). To help distinguish patients in these two groups, conventional magnetic resonance imaging of the brain has been of great benefit in “unmasking” many of these genetic etiologies and has provided important clues to differential diagnosis in others. Recent advances in molecular genetics such as chromosomal microarray and next-generation sequencing have further revolutionized the understanding of etiology by more precisely classifying these disorders with a molecular cause. In this paper, we present a review of neurogenetic disorders masquerading as cerebral palsy evaluated at one institution. We have included representative case examples children presenting with dyskinetic, spastic, and ataxic phenotypes, with the intent to highlight the time-honored approach of using clinical tools of history and examination to focus the subsequent etiologic search with advanced neuroimaging modalities and molecular genetic tools. A precise diagnosis of these masqueraders and their differentiation from CP is important in terms of therapy, prognosis, and family counseling. In summary, this review serves as a continued call to remain vigilant for current and other to-be-discovered neurogenetic masqueraders of cerebral palsy, thereby optimizing care for patients and their families.

AB - An ongoing challenge in children presenting with motor delay/impairment early in life is to identify neurogenetic disorders with a clinical phenotype, which can be misdiagnosed as cerebral palsy (CP). To help distinguish patients in these two groups, conventional magnetic resonance imaging of the brain has been of great benefit in “unmasking” many of these genetic etiologies and has provided important clues to differential diagnosis in others. Recent advances in molecular genetics such as chromosomal microarray and next-generation sequencing have further revolutionized the understanding of etiology by more precisely classifying these disorders with a molecular cause. In this paper, we present a review of neurogenetic disorders masquerading as cerebral palsy evaluated at one institution. We have included representative case examples children presenting with dyskinetic, spastic, and ataxic phenotypes, with the intent to highlight the time-honored approach of using clinical tools of history and examination to focus the subsequent etiologic search with advanced neuroimaging modalities and molecular genetic tools. A precise diagnosis of these masqueraders and their differentiation from CP is important in terms of therapy, prognosis, and family counseling. In summary, this review serves as a continued call to remain vigilant for current and other to-be-discovered neurogenetic masqueraders of cerebral palsy, thereby optimizing care for patients and their families.

KW - Cerebral palsy

KW - Masqueraders

KW - Neurogenetic

KW - Spastic, dyskinetic, and ataxic phenotypes

UR - http://www.scopus.com/inward/record.url?scp=84921937942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921937942&partnerID=8YFLogxK

U2 - 10.1007/s12017-014-8331-9

DO - 10.1007/s12017-014-8331-9

M3 - Article

VL - 16

SP - 821

EP - 844

JO - NeuroMolecular Medicine

T2 - NeuroMolecular Medicine

JF - NeuroMolecular Medicine

SN - 1535-1084

IS - 4

ER -